Amphastar Pharmaceuticals (29A.F) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
0.36
0.51
0.66
0.81

Details

Expected EPS
0.6012321123900001
Actual EPS
0.3581214
Surprise EPS
-0.24
Surprise Percent
-40.44%

Description

⁨Amphastar Pharmaceuticals⁩ (⁦29A.F⁩) has reported earnings of ⁦0.3581214⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts